LASIK Eye Surgery Market-Rising Prevalence of Eye Surgery and increasing Demand for Eye Surgery Accelerate the Growth of the Market

Laser in-situ keratomileusis, i.e.  LASIK is a popular surgery used to correct vision in visually impaired people. It is one of the successful treatment to treat vision impairment.  In this surgery, the ophthalmologist reshapes the cornea to improve the vision.

The market for LASIK surgery is majorly driven by an increasing expenditure on eye health, and growing awareness about eye diseases ad availability of treatment. Furthermore, there is an increase in the number of people suffering from eye diseases across the globe. Technological advancement in the field of ophthalmology also accelerates the growth of the market.

According to the Centre of Disease Control and Prevention, nearly 14 million Americans aged 12 years and older have visual impairment. According to the World Health Organization, about 60 million European have diabetes and the prevalence of diabetes is relatively high among people over 25 years.

Receive a sample copy at https://www.marketresearchfuture.com/sample_request/1774 .

Bausch & Lomb Incorporated.:

November, 2017: Bausch & Lomb Incorporated. launched  expanded parameters of Bausch + Lomb ULTRA  for Astigmatism contact lenses.
October, 2017: Bausch & Lomb Incorporated. announced the introduction of the enVista MX60E with StableFlex technology. This lens is the next generation of the company`s hydrophobic acrylic lens, which provides improved material properties to enhance optic recovery following delivery.
August, 2017: Bausch & Lomb Incorporated.  announced the U.S. launch of the Stellaris Elite vision enhancement system for retina surgery, which integrates advanced retina capabilities into the next-generation surgical platform. This new system features multiple advancements as well as the ability to seamlessly integrate future technologies, such as the Vitesse hypersonic vitrectomy system, which will be exclusive to Stellaris Elite.
July, 2017: Bausch & Lomb Incorporated. announced the U.S. launch of the FortifEYE capsular tension ring (CTR).
Alcon Laboratories, Inc.

Alcon Laboratories, Inc. offers various product from eye care such as contact lenses, dry eye product,k allergy/redness reliefm, eye wash, eye vitamin,, surgical products, vision accessories, safety and industrial cleaning products, and diagnostics.

November, 2017: Alcon Laboratories, Inc. introduced the newly optimized UltraSert delivery system pre-loaded with the AcrySof IQ aspheric monofocal intraocular lens (IOL) for people undergoing cataract surgery at the 2017 American Academy of Ophthalmology (AAO) annual meeting.
October, 2017: Alcon Laboratories, Inc. introduced Clareon the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS).
October, 2017: Alcon announced the US launch of the CyPass Micro-Stent at the annual meeting of the American Academy of Ophthalmology (AAO).
May, 2017: Alcon launched AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens (IOL) with ACTIVEFOCUS optical design at the American Society of Cataract and Refractive Surgery (ASCRS) 2017 annual meeting.
September, 2016: Alcon launched the NGENUITY 3D Visualization System, a platform for Digitally Assisted Vitreoretinal Surgery (DAVS), in collaboration with TrueVision 3D Surgical.  The system is designed to enhance visualization of the back of the eye for improved surgeon experience. TrueVision 3D Surgical is a California-based company specializing in digital 3D visualization and guidance for microsurgery.
Browse Complete Report at https://www.marketresearchfuture.com/reports/lasik-eye-surgery-market-1774

Key players in the LASIK Eye Surgery market:

The global LASIK eye surgery market is highly fragmented with the presence of many local players and international players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

NIDEK CO., LTD. (Japan), Johnson & Johnson (U.S.), Alcon Laboratories, Inc. (U.S.), Carl Zeiss, Inc. (U.S.), Bausch & Lomb Incorporated. (India), Lasersight Technologies, Inc. (U.S.), and others.

Key developments:

Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.

Johnson & Johnson

September, 2016: Johnson & Johnson announced agreement to acquire Abbott Medical Optics. The acquisition will help Johnson & Johnson strengthen global leadership in eye health adding cataract and refractive eye surgery to vision care portfolio. Additionally the company will be able to enter cataract surgery, one of the most commonly performed surgeries and the number one cause of preventable blindness.
iFS Advanced Femtosecond Laser, iDESIGN Advanced WaveScan Studio System, and STAR S4 IR Excimer Laser are the most popular technologies offered by Johnson & Johnson in eye care.
Table of Content

1    INTRODUCTION

2 RESEARCH METHODOLOGY

3 MARKET DYNAMICS

4 MARKET FACTOR ANALYSIS

5 GLOBAL LASIK EYE SURGERY MARKET, BY TYPES

GLOBAL LASIK EYE SURGERY MARKET, BY VISION ERROR
7 GLOBAL LASIK EYE SURGERY MARKET, BY END USER

8 GLOBAL LASIK EYE SURGERY MARKET, BY REGION

9 COMPETITIVE LANDSCAPE

10 COMPANY PROFILE

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us
Market Research Future
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com

This release was published on openPR.